How Does VDTPGCMAF Exactly Work


A 2008 paper on successful cancer treatment using VDTP/GcMAF garnered the world’s attention. It was seemingly the first-ever clinical study of its kind – where all the patients had been successfully treated using the body’s own immune system capabilities. It was a promising feat that made VDTP/GcMAF the new hope for cancer patients across the globe.

However, rather than exploring the potential of this natural cancer immunotherapy, a small faction of the world instead chose to tarnish the study itself. Besides labeling the study as ‘lacking scientific bases’ and ‘baseless conclusions’ – they promoted the traditional treatments of cancer over this natural cancer treatment, without trying to comprehend its efficacy even once.

This became the prime reason as to how this groundbreaking study got buried under the annals of medical history, and VDTP/GcMAF became subject to the unawareness of people.

We have published numerous articles on the effectiveness of VDTP/GcMAF for cancer and even other diseases like autism, multiple sclerosis, and so on.

Let us see what GCMAF actually is and how it works to fight cancer.

We must understand the immune system’s normal functioning

Under physiological conditions, the immune system is programmed to get rid of cancer cells without any foreign intervention. The main task of this natural defense mechanism is to recognize and fight against abnormal cells such as malignant tumor cells, while simultaneously sparing healthy cells and tissue from these ravagers.

This function can be literally translated into so-called “immune surveillance”. When a cell becomes cancerous, it no longer behaves like healthy ones: it expands and divides faster than normal, which is why that is also detected early enough by our immune system.

But then why does our immune system fail against most cancers?

Cancer is a tricky ‘marker’ for the immune system to ‘detect’ and ‘destroy.’ While our white blood cells (also called Macrophages) find and kill cancerous cells in a usual routine, every now and then, a few cancerous cells would escape their surveillance and begin to multiply into a tumor.

These cancer cells cloak themselves through an invisible chemical shield of ‘Nagalase’ (α-N-acetylgalactosaminidase) – something that also stops the production of natural VDTP/GcMAF in the body. Remember, VDTP/GcMAF is critical for activating Macrophages that destroy cancer cells and other pathogens in the body. 

So, how does VDTP/GcMAF Immunotherapy work?

VDTP/GcMAF Immunotherapy works by compensating for the blocked natural MAF by cancer cells’ Nagalase enzyme. This involves giving the patient regular doses of VDTP/GcMAF.

As soon as the body receives its required dose of natural MAF, it triggers warrior white blood cells (macrophages) that then start killing cancerous cells.

If taken in tandem with traditional cancer treatments like chemotherapy, radiation therapy, or surgery – it can work wonders.

You can read more about it here.

Stop misinformation against VDTP/GcMAF.

Share & spread the word!

We do the research you decide,
Love and Light
The Healing Oracle Team
Please join our growing numbers on MeWe: Healing Oracle
Also join us on Twitter | YouTube

Global Petition

Please sign our global petition against enforced vaccinations The intention of this petition is to present 5 million signatures to each President, Prime Minister, Health Minister and heads of state worldwide.
Vaccines are a global problem and need to be tackled on a global level.
If we stand as one, we have a chance of saving the children of the future.

About Healing Oracle

The Healing Oracle team is made up of a group of unpaid volunteers. Collectively we share the same interests and goals and comprise of decades of medical and holistic experience. 

Our mission is to spread our knowledge and experience of the medical world, from both sides of the so called divide between holistic and mainstream practices. There is good and bad on both sides and we hope to unite the best of both worlds.

Please read our philosophy, here in this article from MD Fermin Celma